Casey O'Connell
Medical Director for Anticoagulation Services for LAC+USC
Director, Gehr Cures: Myeloid Malignancy Program of USC
Contact
Keck School of Medicine: Master Teacher Distinction, 2013
LAC+USC Medical Center: Medical Staff Leadership Recognition Award, 2013
Keck School of Medicine : Outstanding Year I Teaching Award, 2012-2013
Keck School of Medicine: Best Year I System, 2011-2012
Keck School of Medicine : Outstanding Year I Teaching Award, 2008-2009
Division of Hematology, USC: Fellow Research Award, 2006-2007
Division of Hematology, USC: Fellow Teaching Award, 2004-2005
USC Department of Medicine: Senior Resident of the Year, 2003-2004
USC Department of Medicine: Brautbar Teaching Award, 2003-2004
Keck School of Medicine: Outstanding Resident Teaching Award, 2003
George Washington University Department of Medicine: Jorge C. Rios Award in Internal Medicine, 2001
: Laszlo M Tauber Scholarship, 1999
George Washington University School of Medicine: William Beaumont Medical Research Honor Society, 1998
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database Leuk Res. 2021 10; 109:106629. . View in PubMed
Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection J Med Virol. 2021 05; 93(5):2645-2653. . View in PubMed
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats Oncologist. 2021 01; 26(1):e8-e16. . View in PubMed
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial Blood Adv. 2020 09 22; 4(18):4282-4291. . View in PubMed
The TEMPI syndrome Blood. 2020 04 09; 135(15):1199-1203. . View in PubMed
Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study Blood. 2020 08 06; 136(6):674-683. . View in PubMed
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia Acta Haematol. 2020; 143(3):244-249. . View in PubMed
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis Blood. 2020 05 07; 135(19):1696-1703. . View in PubMed
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning J Thromb Haemost. 2011 Feb; 9(2):305-11. . View in PubMed
Managing cancer-related venous thromboembolic disease: low-molecular-weight heparins and beyond Expert Rev Hematol. 2008 Dec; 1(2):175-82. . View in PubMed
As director of the new GEHR CURES Myeloid Malignancy Program, Dr. O’Connell is focused on optimizing therapies and on novel ways to intervene earlier to prevent progression of these disorders. Dr. O’Connell is proudest of her accolades for patient care in Southern California and for teaching at the Keck School of Medicine, where she is the Director of the Year II Hematology Course.